Efficacy and safety of lubiprostone in patients with chronic constipation. - Wikidata - wikimedia - TriplyDB

Efficacy and safety of lubiprostone in patients with chronic constipation.

Efficacy and safety of lubiprostone in patients with chronic constipation.

http://www.wikidata.org/entity/Q34088270

about

Consensus statement AIGO/SICCR diagnosis and treatment of chronic constipation and obstructed defecation (part II: treatment)Guidelines for the Diagnosis and Treatment of Chronic Functional Constipation in Korea, 2015 Revised Edition A critical appraisal of lubiprostone in the treatment of chronic constipation in the elderly Current developments in pharmacological therapeutics for chronic constipation Treatment for constipation: new and old pharmacological strategies Novel therapies for constipation ClC-2 regulation of intestinal barrier function: Translation of basic science to therapeutic target Persistent constipation and abdominal adverse events with newer treatments for constipation.Emerging Pharmacologic Therapies for Constipation-predominant Irritable Bowel Syndrome and Chronic Constipation.Understanding and treating refractory constipation.Linaclotide: A new drug for the treatment of chronic constipation and irritable bowel syndrome with constipation Constipation-predominant irritable bowel syndrome: a review of current and emerging drug therapies.Recent advances in pharmacological treatment of irritable bowel syndrome.Chronic constipation in the elderly.Contrasting effects of linaclotide and lubiprostone on restitution of epithelial cell barrier properties and cellular homeostasis after exposure to cell stressors.Lubiprostone: evaluation of the newest medication for the treatment of adult women with constipation-predominant irritable bowel syndrome Current and emerging treatments for irritable bowel syndrome with constipation and chronic idiopathic constipation: focus on prosecretory agents.Treatment of Chronic Constipation: Prescription Medications and Surgical Therapies.Lubiprostone vs Senna in postoperative orthopedic surgery patients with opioid-induced constipation: a double-blind, active-comparator trial.A randomized study of lubiprostone for opioid-induced constipation in patients with chronic noncancer pain.Lubiprostone in constipation: clinical evidence and place in therapy.Long-term safety and effectiveness of lubiprostone, a chloride channel (ClC-2) activator, in patients with chronic idiopathic constipation Diagnosis and treatment of chronic constipation--a European perspective.A randomized, placebo-controlled trial of lubiprostone for opioid-induced constipation in chronic noncancer pain.A comparison of linaclotide and lubiprostone dosing regimens on ion transport responses in human colonic mucosa Chronic constipation in the elderly: a primer for the gastroenterologist Advancing treatment options for chronic idiopathic constipation.Effective Constipation Treatment Changes More Than Bowel Frequency: A Systematic Review and Meta-Analysis.Novel pharmacological therapies for management of chronic constipation.Lubiprostone for the treatment of adult women with irritable bowel syndrome with constipation.Lubiprostone for the treatment of adults with constipation and irritable bowel syndrome.Are constipation drugs effective and safe to be used in children? A review of the literature.A practical approach to diagnosis and management of functional constipation in adults.Safety evaluation of lubiprostone in the treatment of constipation and irritable bowel syndrome.Agents that act luminally to treat diarrhoea and constipation.Pharmacokinetic and pharmacodynamic considerations for the current chronic constipation treatments.Efficacy of pharmacological therapies for the treatment of opioid-induced constipation: systematic review and meta-analysis.Emerging treatments for chronic constipation.Phase II drugs under clinical investigation for the treatment of chronic constipation.American College of Gastroenterology monograph on the management of irritable bowel syndrome and chronic idiopathic constipation.

P2860

Q24633140-7A0282DE-651F-4F85-B89E-4A53CD88B365 Q26745952-0087306E-EF81-43D3-888B-B892BC6280FB Q26824999-0D82E341-2EFA-4E23-A6A9-1EA67B9F14F1 Q27025474-3B3F4528-EDF4-4E26-9EE1-1D3F27B854C3 Q27027346-5D89E714-DF39-4CEC-BF15-69E06DC06521 Q27027873-9491A547-6D16-4BBF-A02E-CFADCDEF6145 Q28066092-36CAD0CD-89F5-45F1-9AEF-E59F39DB7135 Q33468562-A6FCB938-D119-4C36-B8E7-90541A37A002 Q33586854-52477A8E-EC1A-43AF-8CDF-662FAF247AD9 Q33621273-EDF94573-DA6C-452E-B65D-1DB8EA415B1C Q33695487-102690D6-2F29-49B0-AEDA-9A91FD55857B Q33958710-81B923A5-7C0C-4A64-A683-B28AC458E727 Q33958853-A6E1C1D8-C870-4646-8841-3920CBFD2495 Q34223161-8EFB109C-798D-4080-854B-088E82548F63 Q34254749-3D38C518-022F-4483-8605-97B70708281E Q34345704-12B4F026-D334-4B73-AB7F-6F7798BCFC65 Q34478089-434510CF-4355-4A59-BAA4-6A2FBC891F01 Q34522966-3398A5A6-76BD-4DEA-B6C4-CD3A9D010884 Q34552212-D9BEF4E6-1759-4688-A60F-153332BBBB0E Q34805216-386F1BF7-C5D9-48F1-A83B-C63EEB0865C3 Q35091370-5D65741D-C5D2-4556-90CE-38D4E8DE0E6B Q35204780-0A73C3E9-6FE0-4E6A-98F2-A15D66834866 Q35207439-5C7A4E9E-9BF7-4C97-ABB3-9162D42168B8 Q35583262-755981A4-C0FD-4D0D-9744-88355A2DAB66 Q35664952-DC2F6B7D-AA38-4013-98A7-B6FF1F6CC804 Q35807577-518E7921-4AA8-4D21-B0EA-00283793FF10 Q35858864-78C27A86-B95E-492D-A242-7C7F1555AE8A Q36426025-AECC1721-F0A7-4737-AC94-4409096DB703 Q37394824-04C02BB7-4BBD-4763-9EAE-E19D1B571597 Q37704523-8DB20E1C-8CC4-4503-A096-B36F9C0AF8C6 Q37869371-043F3B5D-06D0-4138-A4EA-3AC850A38DB1 Q37908137-7BDE3675-3129-4F42-89BF-2468096DBABE Q37941498-32843B97-4DA8-4259-A3EC-1BA66CB428B6 Q38029718-549701E8-6BAC-4F71-A4A5-87DBBFF17872 Q38040321-39F70F3C-9D1E-4106-AFF5-4233C6C7320C Q38083079-7F7ABE34-2155-4380-B212-B476A1665278 Q38113454-6A2C55AF-D018-49B5-A236-C1CE8E782276 Q38129960-A834E44A-BA28-4674-985A-35F667088F7F Q38222819-7D896CEC-83E8-4E59-9C9E-31F03F911697 Q38236812-C3F35ADC-70BF-432C-A260-41F107B924BE

P2860

Efficacy and safety of lubiprostone in patients with chronic constipation.

http://www.wikidata.org/entity/Q34088270

description

2009 nî lūn-bûn

@nan

2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Efficacy and safety of lubiprostone in patients with chronic constipation.

@ast

Efficacy and safety of lubiprostone in patients with chronic constipation.

@en

Efficacy and safety of lubiprostone in patients with chronic constipation.

@nl

type

label

Efficacy and safety of lubiprostone in patients with chronic constipation.

@ast

Efficacy and safety of lubiprostone in patients with chronic constipation.

@en

Efficacy and safety of lubiprostone in patients with chronic constipation.

@nl

prefLabel

Efficacy and safety of lubiprostone in patients with chronic constipation.

@ast

Efficacy and safety of lubiprostone in patients with chronic constipation.

@en

Efficacy and safety of lubiprostone in patients with chronic constipation.

@nl

P1433

Q34088270-4EEBAEF1-6959-4F7E-B07E-0BEFAE74B699

P1476

Q34088270-56230E39-B91A-4AD2-A478-9B555F0353F0

P2093

Q34088270-209F52D9-98AD-44F9-813D-14A5456EC47C

Q34088270-81022F4B-3AE4-47ED-8BC9-6FDA56D4991D

Q34088270-88F664E0-6E74-4245-866C-0772410E183F

Q34088270-E22C4473-94D4-4B49-9FB7-CE455EB172CD

P2860

Q34088270-B8707070-26F6-4735-97B2-99F7348439F0

P2888

Q34088270-7458AC94-C67C-4BC0-A468-5F596586F41F

P304

Q34088270-82F00AEA-E930-4988-A1DB-8ACCD06819F9

P31

Q34088270-04E12FC9-5D17-4FFA-B443-F14AEC606AAA

P356

Q34088270-D1C17CCD-71DD-4CB2-A40C-47FCAA477242

P433

Q34088270-FE3CE505-48B3-458E-B812-7D396C937539

P478

Q34088270-2E9FCDB8-D853-4270-B654-9F63EADE6FEC

P577

Q34088270-B79FAD4E-F9DF-4B2D-8DA5-BD62FB9D6936

P5875

Q34088270-B94E9A63-D045-45A9-B29E-C065A2A01356

P6179

Q34088270-0A6A2E86-4CE6-49E9-BE86-72AD2046CAE5

P698

Q34088270-0EB054D8-F7C4-4ED0-9BEE-47BE1EF035E6

P921

Q34088270-2861126F-4DA7-4C0C-B01B-7C3794F32E78

P356

S10620-009-1068-X

P1433

Digestive Diseases and Sciences

P1476

Efficacy and safety of lubiprostone in patients with chronic constipation.

@en

P2093

Charles F Barish

http://www.w3.org/2001/XMLSchema#string

Douglas Drossman

http://www.w3.org/2001/XMLSchema#string

John F Johanson

http://www.w3.org/2001/XMLSchema#string

Ryuji Ueno

http://www.w3.org/2001/XMLSchema#string

P2860

Multicenter, 4-week, double-blind, randomized, placebo-controlled trial of lubiprostone, a locally-acting type-2 chloride channel activator, in patients with chronic constipation.

P2888

s10620-009-1068-x

P304

1090-1097

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10620-009-1068-X

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

55

http://www.w3.org/2001/XMLSchema#string

P577

2009-12-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

40689916

http://www.w3.org/2001/XMLSchema#string

P6179

1049603349

http://www.w3.org/2001/XMLSchema#string

P698

20012484

http://www.w3.org/2001/XMLSchema#string

P921